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This case report describes the treatment of atrial ﬁbrillation (AF) in a patient with Brugada
syndrome. We found the triggers of AF in the superior vena cava during electrophysiological
study and the isolation of superior vena cava with catheter ablation successfully eliminated
the recurrence of AF. This case suggests that abnormal myocardial repolarization due to Naþ-
channel abnormality is not always the etiology of AF in patients with Brugada syndrome. In
case of the focal trigger related to the initiation of AF, catheter ablation can be an eﬀective
therapeutic strategy.
(J Arrhythmia 2005; 21: 470–474)
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Introduction
It is reported that myocardial abnormal repolari-
zation due to Naþ-channel abnormalities is associ-
ated with the occurrence of atrial ﬁbrillation (AF)
and ventricular ﬁbrillation (VF) in patients with
Brugada syndrome (BS).1,2) Recently, Haissaguerre
et al. suggested ablation of the foci of premature
beats preceding the ventricular tachyarrhythmias is
associated with better clinical outcomes in patients
with BS.3) It remains unknown that such focal
triggers also contribute to AF in patients with BS.
Case Report
A 55-year-old man complained of paroxysmal
palpitation for 15 years. He was diagnosed with
paroxysmal AF 5 years ago, and received disopyr-
amide. He was referred to our hospital due to sudden
and severe palpitation and dizziness on August 17th,
2004. In the ambulance, the ECG showed mono-
morphic wide QRS tachycardia (Figure 1). Just
before the hospital arrival, wide QRS tachycardia
turned to narrow QRS morphology and 12-lead ECG
showed coved-type ST segment elevation in V1 and
V2 leads (Figure 2). Atrial rhythm suspected of atrial
ﬂutter spontaneously changed to sinus rhythm. Chest
X-ray ﬁnding and laboratory data were normal.
Echocardiographic ﬁndings were also normal (left
atrial dimension = 32mm, left ventricular ejection
fraction = 69%). After the intravenous administra-
tion of pilsicainide, further elevation of coved-type
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Case Report
ST segment was noted in V1–V3 (Figure 3) and he
was diagnosed with BS. He had no family history of
sudden cardiac death. He had experienced syncope
once when he was 53 years old.
After obtaining written informed consent, we
conducted the electrophysiological study. After
intravenous isoproterenol infusion (3.0mcg/min),
we found the premature beats originated from the
superior vena cava (SVC), followed by atrial
tachycardia (Figure 4). Atrial tachycardia spontane-
ously shifted to AF (Figure 5). We found local high
frequency and centrifugal activation within SVC and
pulmonary veins. The activation patterns were
periodical. Thus, we conducted electrical segmental
isolation for the ostium of the SVC and for each
pulmonary vein. The isolation procedure for SVC
breakthrough site was accomplished by two radio-
frequency energy applications targeted at 50 degrees
within 30W (Japan Lifeline, Abraze, Tokyo). Al-
though the abnormal activation remained within
SVC, sinus rhythm was maintained after the elec-
trical SVC isolation, (Figure 6). We could not induce
ventricular tachycardia or atrial ﬂutter with the
standard programmed electrical stimulation protocol.
Programmed ventricular stimulation was performed
consisting of single, double and triple extrastimuli
during paced rhythm with basic cycle lengths of 600
and 400ms; and burst pacing up to 240 beats per
minute with and without isoproterenol. HV interval
was not signiﬁcantly prolonged (45ms). Implantable
cardioverter deﬁbrillator (ICD) was not implanted
because of patient’s rejection. The patient was
discharged without the medications and maintained
good condition without recurrence of AF and
ventricular tachyarrhythmia (follow-up period: 12
months).
Discussion
To our knowledge, this is the ﬁrst case report
Figure 1 Monitor ECG demonstrated monomorphic wide QRS tachycardia without hemodynamic compromise.
Figure 2 Remarkable coved type ST segment elevation was demonstrated in leads V1 to V3 with slight QRS width
prolongation.
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documenting that AF foci was identiﬁed and was
successfully treated with catheter ablation in a
patient with BS. BS is an arrhythmogenic disease
characterized by the right bundle branch block with
ST-segment elevation in right precordial leads and
with a high risk of life threatening ventricular
tachyarrhythmia.4–7) AF also sometimes occurs in
patients with BS.2,8) Naþ channel abnormality is
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Figure 4 Catheter electrodes were located in SVC, RSPV, LSPV and LIPV.
The earliest activation site of PB was in upper SVC level shown by black arrow. Atrial tachycardia spontaneously shifted to
atrial ﬁbrillation (AF). SVC: superior vena cava, RSPV: right superior pulmonary vein, LSPV: left superior pulmonary vein,
LIPV: left inferior pulmonary vein, PB: premature beat
Figure 3 Remarkable ST-T seg-
ment coved type elevation was dem-
onstrated after intravenous pilsica-
nide administration.
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common etiology of BS and it is generally consid-
ered that the altered action potential in atrial and
ventricular cells should be a cause of AF and
ventricular tachyarrhythmia, respectively, in patients
with BS. Therefore, we have not considered the
contribution of focal electrical abnormality to the AF
and ventricular tachyarrhythmias. A recent study
demonstrates the focal triggers have an important
role in the development of ventricular tachyarrhyth-
mias associated with BS, and the ablation led to a
dramatic improvement in the subsequent clinical
course.3) Bordachar et al. suggested that the preced-
ing atrial premature beats are likely to be associated
with the occurrence of AF on ambulatory ECG
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Figure 5 Atrial tachycardia spontaneously shifted to atrial ﬁbrillation (AF).
High frequent and fragmented potentials of pulmonary veins and right atrium were recorded during AF.
LSPV: left superior pulmonary vein, LIPV: left inferior pulmonary vein, HRA: high right atrium, RSPV:
right superior pulmonary vein
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Figure 6 Sinus rhythm recovered after electrical isolation for SVC, however atrial ﬁbrillation remained in
the SVC electrocardiogram.
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recordings in patients with BS.8) Therefore, we
hypothesized that the focal triggers may play an
important role in AF and was not caused solely by an
abnormal myocardial substrate. Anti-arrhythmic
agents may promote the occurrence of ventricular
tachyarrhythmias, thus the catheter ablation for AF is
an eﬀective alternative treatment strategy in patients
with BS. ICD therapy and atrial isthmus ablation
may be required in this case, however the program-
med electrical stimulation protocol failed to induce
life threatening ventricular arrhythmia and atrial
ﬂutter without disopyramide. These electrophsiolog-
ical ﬁndings suggest that wide QRS tachycardia and
atrial ﬂutter could result from the inadequate use of
anti-arrhythmia drugs.
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